# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-053978
Filing Date
2024-04-29
Accepted
2024-04-29 16:00:07
Documents
6
Period of Report
2024-06-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm242728-2_def14a.htm | DEF 14A | 912222
2 | GRAPHIC | lg_scholarrock-4c.jpg | GRAPHIC | 127365
3 | GRAPHIC | bc_actualpaidvstsr-4c.jpg | GRAPHIC | 57043
4 | GRAPHIC | bc_actualpaidvsnetincome-4c.jpg | GRAPHIC | 57308
5 | GRAPHIC | px_24scholarproxy1pg01-bw.jpg | GRAPHIC | 314923
6 | GRAPHIC | px_24scholarproxy1pg02-bw.jpg | GRAPHIC | 299208
| Complete submission text file | 0001104659-24-053978.txt |  | 2047903

Mailing Address 301 BINNEY STREET 3RD FLOOR CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET 3RD FLOOR CAMBRIDGE MA 02142 857-259-3860
Scholar Rock Holding Corp (Filer) CIK: 0001727196 (see all company filings)

EIN.: 823750435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38501 | Film No.: 24890419
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)